About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Based on the one-year price targets offered by 10 analysts, the average target price for Avadel Pharmaceuticals PLC (NASDAQ:AVDL) is $23.30 with a high estimate of $27.00 and a low estimate of $20.00.